Brain metastasis in breast cancer: a comprehensive literature review Rezvan RostamiShivam MittalBahman Jabbari Topic Review 24 February 2016 Pages: 407 - 414
Positron emission tomography of high-grade gliomas Guido Frosina Topic Review 20 February 2016 Pages: 415 - 425
The challenges associated with molecular targeted therapies for glioblastoma Toni Rose JueKerrie L. McDonald Topic Review 22 February 2016 Pages: 427 - 434
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system Johannes van de NesMarco GessiKlaus G. Griewank Laboratory Investigation 07 January 2016 Pages: 435 - 444
The effects of antiepileptic drugs on the growth of glioblastoma cell lines Ching-Yi LeeHung-Yi LaiShih-Tseng Lee Laboratory Investigation Open access 13 January 2016 Pages: 445 - 453
Long-term exposure to irinotecan reduces cell migration in glioma cells A. B. Al-GhafariW. PunjarukI. D. Kerr Laboratory Investigation 30 January 2016 Pages: 455 - 462
Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy James R. HandsGraeme ClemensMatthew J. Baker Laboratory Investigation Open access 13 February 2016 Pages: 463 - 472
In vivo multiphoton tomography and fluorescence lifetime imaging of human brain tumor tissue Sven R. KantelhardtDarius KalasauskasAlf Giese Laboratory Investigation 30 January 2016 Pages: 473 - 482
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma Soma GhasimiCarl WibomBeatrice Melin Laboratory Investigation Open access 02 February 2016 Pages: 483 - 492
The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter? D. T. BlumenthalL. MendelF. Bokstein Clinical Study 31 December 2015 Pages: 493 - 502
Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter? D. T. BlumenthalL. MendelF. Bokstein Erratum 08 March 2016 Pages: 503 - 503
Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide Navid RedjalClemens ReinshagenBrian V. Nahed Clinical Study 01 February 2016 Pages: 505 - 514
Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI Moran ArtziGilad LibermanDafna Ben Bashat Clinical Study 11 January 2016 Pages: 515 - 524
Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer Ren YuanAndrew YamadaCheryl Ho Clinical Study 16 January 2016 Pages: 525 - 533
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas Wenyin ShiJoshua D. PalmerYaacov R. Lawrence Clinical Study 29 January 2016 Pages: 535 - 539
The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area Jaejoon LimKyunggi Cho Clinical Study Open access 17 February 2016 Pages: 541 - 550
Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery Amir ZolalTareq A. JuratliDietmar Krex Clinical Study 30 January 2016 Pages: 551 - 557
Cognitive screening in patients with intracranial tumors: validation of the BCSE Juliane BeckerElisabeth SteinmannSimone Goebel Clinical Study 01 February 2016 Pages: 559 - 567
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial Carmen BalanaRamon De Las PenasSalvador Villà Clinical Study 03 February 2016 Pages: 569 - 579
Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles? Sebastian AdebergChristian DiehlJürgen Debus Clinical Study 30 January 2016 Pages: 581 - 587
“Comet tail sign”: A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors Koichi MitsuyaYoko NakasuMasahiro Endo Clinical Study Open access 02 February 2016 Pages: 589 - 595
Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients Mostafa FarzinMichael MollsChristoph Straube Clinical Study 06 February 2016 Pages: 597 - 606
Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases Amparo WolfSayyad ZiaDouglas Kondziolka Clinical Study 06 February 2016 Pages: 607 - 615
Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach Giordano SavelliMirco BartolomeiMario Bignardi Letter to the Editor 02 February 2016 Pages: 617 - 619